| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0079
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0681
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-32 |
| filingDate |
2011-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2013-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2013521995-A |
| titleOfInvention |
Endovascular tissue destruction |
| abstract |
Tissue destruction and devices and systems for tissue destruction. The present disclosure describes a method of delivering a portion to a target tissue that is generally not at the introduction point in such a way that minimal damage is caused in the tissue at the introduction point. In some embodiments, this is achieved by ejecting fluid at a high rate to the target tissue. The present disclosure further describes novel agents that can be delivered with such a system for use in tissue remodeling. Some of these drugs include liquids and some do not include liquids. Furthermore, although not specifically described in detail, most of the present disclosure can be further used for the delivery of therapeutic agents. [Selection] Figure 16 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016524515-A |
| priorityDate |
2010-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |